• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
CHEN Jiaqi,ZHOU Pengjun,YAN Lihong,YANG Zhongduo,SUN Peng,HU Jinfeng.Research progress on triterpenoids from rare and endangered plants of the Pineceae family and their biological activities[J].Journal Of Pharmaceutical Research,2026,45(5):552-561[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 1550times   Download 767次 QR Code for this article
Scan with your phone!
松科稀有濒危植物中三萜成分及其生物活性研究进展
陈佳琦1,周鹏军2,3,4,颜鹂鸿2,杨中铎1,孙鹏5,胡金锋2,3,4
Font:Larger+|Default|Smaller-
(1.兰州理工大学生命科学与工程学院,甘肃 兰州 730050;2.台州学院药学院,浙江 台州 318000;3.四川轻化工大学化学工程学院,四川 自贡 643002;4.复旦大学药学院,上海 201203;5.全省特色抗感染药物生物制造重点实验室,浙江海正药业股份有限公司,浙江 台州 318000)
摘要:
松科位列主要产药植物科属之一,其化学成分结构复杂多样。前期已有多篇文献对松科植物化学成分及其生物活性进行了总结,其中三萜类化合物因结构丰富多样、生物活性突出而成为研究热点。统计表明,稀有濒危植物的成药性较好。我国松科植物虽资源丰富,但有相当比例的物种其生存受威胁程度较高,在国内和国际多个保护名录中被列为稀有濒危植物。本文聚焦近五年(2020—2025)松科稀有濒危植物中三萜类成分的研究进展,围绕化学结构多样性及主要生物活性进行系统性综述,以期为松科珍稀植物资源的药用价值发现、科学保护与可持续利用提供科学依据。
关键词:  松科  稀有濒危植物  三萜类化合物  化学成分  生物活性
DOI:10.13506/j.cnki.jpr.2026.05.011
基金项目:国家自然科学基金重点项目(No.21937002)
Received Date:December 08, 2025   Revision Date:January 22, 2026   Publication Date:May 29, 2026
Research progress on triterpenoids from rare and endangered plants of the Pineceae family and their biological activities
CHEN Jiaqi1,ZHOU Pengjun2,3,4,YAN Lihong2,YANG Zhongduo1,SUN Peng5,HU Jinfeng2,3,4
(1. School of Life Science and Engineering, Lanzhou University of Technology, Lanzhou 730050, China; 2. School of Pharmaceutical Science, Taizhou University, Taizhou 318000, China; 3. School of Chemical Engineering, Sichuan University of Science & Engineering, Zigong 643002, China; 4. School of Pharmacy, Fudan University, Shanghai 201203, China; 5. Zhejiang Key Laboratory of Special Anti-infective Drugs Bio-manufacturing, Zhejiang Hisun Pharmaceutical Co., Ltd., Taizhou, 318000, China)
Abstract:
The Pinaceae family is one of the major taxonomic groups of medicinal plants, distinguished by a highly diverse and structurally complex repertoire of chemical constituents. Numerous studies have previously reviewed the phytochemistry and bioactivities of Pinaceae species, among which triterpenoids have attracted significant interest owing to their structural diversity and prominent bioactivities. Existing evidence suggests that rare and endangered plants exhibit a relatively high degree of medicinal potential. Although China harbors abundant Pinaceae resources, a considerable proportion of species have already been listed in national and international conservation catalogues as rare and endangered plants, indicating that they are facing substantial threat. This article focuses on the recent five years (2020—2025) of research progress on triterpenoids from rare and endangered Pinaceae species, with particular emphasis on the structural diversity of these compounds and their major biological activities. The aim is to offer a scientific basis for discovering the medicinal value of these precious plant resources and for promoting their conservation and sustainable utilization.
Key words:  Pinaceae  Rare and endangered plants  Triterpenoids  Chemical constituents  Biological activities
Today's Visits:485    Total Visits:2383197
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.